Tag:
Dengvaxia
Latest Headlines
Latest Headlines
NIH-developed dengue vaccine protects all patients in challenge study
As Sanofi works to gain traction for the launch of its world-first dengue vaccine, a potential competitor may be building its case. This week, the National Institutes of Health announced that a candidate developed by scientists there posted "very encouraging" results, according to the team's lead scientist.
Philippines' immunization program for Sanofi's Dengvaxia set to start in April
Sanofi's Dengvaxia is set for a wide rollout in the Philippines, making the endemic nation the first to implement an immunization campaign utilizing the dengue fever vaccine.
Sanofi ships 1M Dengvaxia doses to Philippines, in talks for 3M more at €20 a dose
Sanofi is moving into 2016 with a head of steam for its Dengvaxia launch, with execs announcing on the company's year-end conference call that the French pharma has delivered its first million doses in the Philippines.
Sanofi banks on Philippines to lead public Dengvaxia rollout
The high-stakes rollout of Sanofi's dengue vaccine, Dengvaxia, is slated this month in the private market, the lead executive for the product said, adding that a tender for 3 million doses is in advanced discussions in the Philippines for a public launch within weeks.
Sanofi working with health authorities on dengue vaccine strategies
Sanofi Pasteur spent 20 years and $1.5 billion researching its dengue fever vaccine, Dengvaxia, and now it's looking to maximize the vaccine's impact. To do that, the French pharma's vaccine division is working with regulators and health officials to identify implementation strategies, program head Guillaume Leroy told FierceVaccines.
Sanofi may get waiver from large-scale dengue vaccine trials in India
A waiver of large-scale clinical trials for Sanofi's dengue vaccine, Dengvaxia, was recommended by a special committee that advises the Drug Controller General of India, the Economic Times reports.
Sanofi's dengue vaccine gets first Asian approval with more discussions underway
The Philippines' FDA approved Sanofi's first-of-its-kind dengue fever vaccine, Dengvaxia, on Tuesday. And on the same day, India's Economic Times reported that the government there is exploring opportunities to accelerate marketing authorization for the vaccine, considering exempting it from large local clinical trials.
